ROST
57
-3
DLTR
38
-4
MS
77
-2
SIG
44
-3
TRIP
50
-4
IRM
41
3
COP
57
-2
CINF
53
3
MUR
44
-3
TXT
53
-3
ETR
65
2
CNX
73
-3
LMT
30
-2
AME
74
-4
ICE
59
-3
LEN
50
-2
PLD
45
-5
IR
63
-3
MTCH
20
-8
ADM
28
3
ROST
57
-3
DLTR
38
-4
MS
77
-2
SIG
44
-3
TRIP
50
-4
IRM
41
3
COP
57
-2
CINF
53
3
MUR
44
-3
TXT
53
-3
ETR
65
2
CNX
73
-3
LMT
30
-2
AME
74
-4
ICE
59
-3
LEN
50
-2
PLD
45
-5
IR
63
-3
MTCH
20
-8
ADM
28
3
Financhill
Back

Alnylam Pharmaceuticals Vs. Repligen Industry Stock Comparison

Sell
20

ALNY
Alnylam Pharmaceuticals

Last Price:
235.53
Seasonality Move:
10.85%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
20
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $235.56. The Score for ALNY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $235.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.97 Sell
Relative Strength Index (14 RSI): 27.06 Sell
Chaikin Money Flow: -1631558 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (264.56 - 293.18) Sell
Bollinger Bands (100): (249.23 - 281.59) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 266.17 Sell
20-day SMA: 276.01 Sell
50-day SMA: 273.94 Sell
200-day SMA: 209.89 Buy
8-day EMA: 261.6 Sell
20-day EMA: 270.55 Sell
50-day EMA: 270.52 Sell
200-day EMA: 230.49 Buy

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):